Wasted time is the enemy of cancer patients.
KIYATEC’s mission is to change the future of cancer care by accurately predicting patient-specific response and non-response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality.
Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and the NCI. We are conducting robust clinical trials to fully demonstrate the power of our approach and earn widespread adoption for a broad portfolio of products predicting response to today’s and tomorrow’s therapies. www.kiyatec.com
Location: United States, South Carolina, Greenville
Employees: 11-50
Total raised: $25.8M
Founded date: 2005
Investors 4
| Date | Name | Website |
| - | AIM Group | aimgr.com |
| - | Esperante | esperante.... |
| - | Atlanta Te... | angelatlan... |
| - | Collective... | ccventures... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 12.12.2022 | Series C | $18M | - |
| 15.12.2021 | - | $5M | - |
| 24.05.2012 | - | $2.8M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 18.05.2023 | Kiyatec Receives Investment from Brain Cancer Venture Philan... | Kiyatec, a Greenville, SC-based functional precision oncology company, received an investment from T... | finsmes.co... |
| 12.12.2022 | Kiyatec Closes US$18M in Series C | Kiyatec, a Greenville, SC-based precision oncology company, raised US$18M in Series C funding. The ... | finsmes.co... |
| 12.12.2022 | Kiyatec Announces Series C Round with $18 Million | GREENVILLE SC, Kiyatec Inc., announced a closing of its Series C funding round totaling $18 millio... | vcnewsdail... |
| 21.09.2021 | KIYATEC : Announces Addition of Chief Commercial Officer Sta... | The functional precision oncology company KIYATEC, Inc. announced today the addition of Chief Commer... | marketscre... |
| 30.04.2021 | KIYATEC Announces $2,5M Investment | GREENVILLE, SC, KIYATEC has secured a $2.5 million investment from Seae Ventures. >> Click ... | vcnewsdail... |
| 01.05.2019 | KIYATEC Announces $3M Initial Closing of Series B2 Preferred... | GREENVILLE, S.C.--(BUSINESS WIRE)--KIYATEC, Inc. today announced the initial $3 million closing of t... | citybizlis... |
| 01.05.2019 | KIYATEC Announces $3M Initial Closing of Series B2 Preferred... | GREENVILLE, S.C.--(BUSINESS WIRE)--KIYATEC, Inc. today announced the initial $3 million closing of t... | archive.ci... |
| 24.05.2012 | Cell cultures in 3-D — KIYATEC raises $2.8M for novel testin... | “The ability to detect a compound that would otherwise fail in clinical trials, before it is used in... | medcitynew... |
| 23.05.2012 | KIYATEC Raises Series A Funding | KIYATEC Inc., a Pendleton, SC-based life sciences company, has held the initial close of its Series ... | finsmes.co... |
| - | Cell cultures in 3-D — KIYATEC raises $2.8M for novel testin... | Cell culture testing technology developed by KIYATEC aims to help drug developers find out in precli... | medcitynew... |
Show more